4.6 Article

Transcriptional Coactivator TAZ Negatively Regulates Tumor Suppressor p53 Activity and Cellular Senescence

Journal

CELLS
Volume 9, Issue 1, Pages -

Publisher

MDPI
DOI: 10.3390/cells9010171

Keywords

cellular senescence; oncogene; p300; p53; TAZ

Categories

Funding

  1. Japan Society for the Promotion of Science (JSPS) [15K07936, 15K07937, 18K06660]
  2. JSPS [18K16081]
  3. Mochida Memorial Foundation for Medical and Pharmaceutical Research
  4. Takeda Science Foundation
  5. INAMORI Foundation
  6. Aichi Cancer Research Foundation
  7. Ichiro Kanehara Foundation
  8. ONO Medical Research Foundation

Ask authors/readers for more resources

Transcriptional coactivator with a PDZ-binding motif (TAZ) is one of the mammalian orthologs of Drosophila Yorkie, a transcriptional coactivator of the Hippo pathway. TAZ has been suggested to function as a regulator that modulates the expression of cell proliferation and anti-apoptotic genes in order to stimulate cell proliferation. TAZ has also been associated with a poor prognosis in several cancers, including breast cancer. However, the physiological role of TAZ in tumorigenesis remains unclear. We herein demonstrated that TAZ negatively regulated the activity of the tumor suppressor p53. The overexpression of TAZ down-regulated p53 transcriptional activity and its downstream gene expression. In contrast, TAZ knockdown up-regulated p21 expression induced by p53 activation. Regarding the underlying mechanism, TAZ inhibited the interaction between p53 and p300 and suppressed the p300-mediated acetylation of p53. Furthermore, TAZ knockdown induced cellular senescence in a p53-dependent manner. These results suggest that TAZ negatively regulates the tumor suppressor functions of p53 and attenuates p53-mediated cellular senescence.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available